Serial H3K27M cell-free tumor DNA (cf-tDNA) tracking predicts ONC201 treatment response and progression in diffuse midline glioma is a research paper published in Neuro-Oncology (2022). On theSindex it has a DataRank of 3.4. It has been cited 122 times, with 97 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
Repositories this paper deposited data in (declared in PubMed).
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.722
From this paper's citation signal
Citation Network Contribution
2.7
From 71 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 97 citers.
NINDS
Grant: K08-NS099427
NINDS
Grant: R01-NS119231
Department of Defense
Grant: CA201129P1
NINDS NIH HHS
Grant: K08 NS099427
NINDS NIH HHS
Grant: R01 NS119231
NINDS NIH HHS
Grant: R01 NS110572
NINDS NIH HHS
Grant: R01 NS124607
National Institutes of Health
Grant: 5K08NS099427-03
Targeting ATRX-Deficient Pediatric GBM
National Institutes of Health
Grant: 5R01NS124607-03
Targeting EGFR/FOXG1-mediated resistance to ONC201 in H3K27M-mutant diffuse midline glioma
National Institutes of Health
Grant: 5R01NS119231-04
The role of ATRX mutation in the epigenetic dysregulation of cell cycle in pediatric high-grade glioma
National Institutes of Health
Grant: 5R01NS110572-05
Unraveling metabolic dependencies in H3K27M mutant Diffuse Intrinsic Pontine Gliomas
NIH
FWCI
15.42
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals